These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 30995454)

  • 1. BZ043, a novel long-acting amylin analog, reduces gastric emptying, food intake, glycemia and insulin requirement in streptozotocin-induced diabetic rats.
    Nascimento CVMF; Sinezia C; Sisnande T; Lima LMTR; Lacativa PGS
    Peptides; 2019 Apr; 114():44-49. PubMed ID: 30995454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physico-chemical stability of co-formulation of PEGylated human amylin with insulin.
    Sinésia C; do Nascimento CVMF; Lacativa PGS; Lima LMTR
    Pharm Dev Technol; 2019 Oct; 24(8):975-981. PubMed ID: 31124388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of single doses of pramlintide on gastric emptying of two meals in men with IDDM.
    Kong MF; Stubbs TA; King P; Macdonald IA; Lambourne JE; Blackshaw PE; Perkins AC; Tattersall RB
    Diabetologia; 1998 May; 41(5):577-83. PubMed ID: 9628276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultra-Fast Insulin-Pramlintide Co-Formulation for Improved Glucose Management in Diabetic Rats.
    Maikawa CL; Chen PC; Vuong ET; Nguyen LT; Mann JL; d'Aquino AI; Lal RA; Maahs DM; Buckingham BA; Appel EA
    Adv Sci (Weinh); 2021 Nov; 8(21):e2101575. PubMed ID: 34499434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute intraperitoneal administration of taurine decreases the glycemia and reduces food intake in type 1 diabetic rats.
    Gomez R; Caletti G; Arbo BD; Hoefel AL; Schneider R; Hansen AW; Pulcinelli RR; Freese L; Bandiera S; Kucharski LC; Barros HMT
    Biomed Pharmacother; 2018 Jul; 103():1028-1034. PubMed ID: 29710660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infusion of pramlintide, a human amylin analogue, delays gastric emptying in men with IDDM.
    Kong MF; King P; Macdonald IA; Stubbs TA; Perkins AC; Blackshaw PE; Moyses C; Tattersall RB
    Diabetologia; 1997 Jan; 40(1):82-8. PubMed ID: 9028722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Amylin/IAPP (islet amyloid polypeptide)--physiology and clinical significance].
    Ludvik B
    Wien Klin Wochenschr; 1997 Jun; 109(11):379-83. PubMed ID: 9281227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of amylin in nutrient intake - animal studies.
    Young A
    Diabet Med; 1997 Jun; 14 Suppl 2():S14-8. PubMed ID: 9212324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastric emptying is accelerated in diabetic BB rats and is slowed by subcutaneous injections of amylin.
    Young AA; Gedulin B; Vine W; Percy A; Rink TJ
    Diabetologia; 1995 Jun; 38(6):642-8. PubMed ID: 7672483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amylin replacement with pramlintide as an adjunct to insulin therapy in type 1 and type 2 diabetes mellitus: a physiological approach toward improved metabolic control.
    Weyer C; Maggs DG; Young AA; Kolterman OG
    Curr Pharm Des; 2001 Sep; 7(14):1353-73. PubMed ID: 11472273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of pramlintide, an amylin analogue, on gastric emptying in type 1 and 2 diabetes mellitus.
    Vella A; Lee JS; Camilleri M; Szarka LA; Burton DD; Zinsmeister AR; Rizza RA; Klein PD
    Neurogastroenterol Motil; 2002 Apr; 14(2):123-31. PubMed ID: 11975712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-acting hypoglycemic effects of PEGylated FGF21 and insulin glargine in mice with type 1 diabetes.
    Xu P; Ye X; Zhang Y; Yuan Q; Liu M; Wu Q; Ren G; Li D
    J Diabetes Complications; 2015; 29(1):5-12. PubMed ID: 25456819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoconjugation of Human Amylin with Methylpolyethyleneglycol.
    Sisnande T; Guerreiro LH; Braga RR; Jotha-Mattos L; Erthal LC; Tinoco P; Ferreira BM; Lima LM
    PLoS One; 2015; 10(10):e0138803. PubMed ID: 26448437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The human amylin analog, pramlintide, corrects postprandial hyperglucagonemia in patients with type 1 diabetes.
    Fineman MS; Koda JE; Shen LZ; Strobel SA; Maggs DG; Weyer C; Kolterman OG
    Metabolism; 2002 May; 51(5):636-41. PubMed ID: 11979398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amylin and the gastrointestinal tract.
    Macdonald IA
    Diabet Med; 1997 Jun; 14 Suppl 2():S24-8. PubMed ID: 9212326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amylin reduces plasma glucagon concentration in cats.
    Furrer D; Kaufmann K; Reusch CE; Lutz TA
    Vet J; 2010 May; 184(2):236-40. PubMed ID: 19299171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Amylin in Type 1 and Type 2 Diabetes.
    Hieronymus L; Griffin S
    Diabetes Educ; 2015 Dec; 41(1 Suppl):47S-56S. PubMed ID: 26424675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].
    Hauner H; Kohlmann T; Landgraf W; Holle R; Pirk O; Scholten T
    Dtsch Med Wochenschr; 2009 Jun; 134(23):1207-13. PubMed ID: 19472091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoglycemia overrides amylin-mediated regulation of gastric emptying in rats.
    Gedulin BR; Young AA
    Diabetes; 1998 Jan; 47(1):93-7. PubMed ID: 9421380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amylin induces hypoglycemia in mice.
    Guerreiro LH; Da Silva D; Sola-Penna M; Mizurini DM; Lima LM
    An Acad Bras Cienc; 2013 Mar; 85(1):349-54. PubMed ID: 23460444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.